Cardiovascular disease in patients with non-alcoholic fatty liver disease.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 24713805)

Published in Ann Gastroenterol on January 01, 2012

Authors

Konstantinos Kantartzis1, Norbert Stefan1

Author Affiliations

1: Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, University of Tübingen and Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen (Paul Langerhans Institute Tübingen), Tübingen, Germany.